Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Breast Neoplasms (Phase 1)
Carcinoma (Phase 1)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 1/Phase 2)
Colorectal Neoplasms (Phase 1)
Deficiency Diseases (Phase 3)
Glioblastoma (Phase 1)
Glioma (Phase 1)
Hamartoma (Phase 1)
Hyperargininemia (Phase 3)
Intestinal Neoplasms (Phase 1)
Leukemia (Phase 1)
Leukemia, Lymphoid (Phase 1/Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lymphoma (Phase 1)
Lymphoma, Non-Hodgkin (Phase 2)
Melanoma (Phase 2)
Mesothelioma (Phase 2/Phase 3)
Mesothelioma, Malignant (Phase 2)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 1/Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Obesity (Phase 2)
Ovarian Neoplasms (Phase 1)
Pancreatic Neoplasms (Phase 1)
Prediabetic State (Phase 2)
Prostatic Neoplasms (Phase 1/Phase 2)
Sarcoma (Phase 3)
Skin Neoplasms (Phase 1/Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Stomach Neoplasms (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue